Literature DB >> 7527334

Expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone.

M A Gosteli-Peter1, K H Winterhalter, C Schmid, E R Froesch, J Zapf.   

Abstract

The expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 (IGFBP-2), -3, -4, and -5 messages were studied in liver, kidney, spleen, thymus, heart, brain, skeletal muscle, testes, and epididymal (white) adipose tissue (WAT) from hypophysectomized rats infused with saline, recombinant human (rh) IGF-I, or rhGH and compared with tissue messenger RNA (mRNA) levels in age-matched normal rats. The IGF-I message was present in all of these tissues. It was most abundant in liver and WAT, but was barely detectable in kidney, brain, and thymus. GH dependence was most pronounced in liver, skeletal muscle, and WAT and less so in heart, testes, kidney, spleen, and thymus. The IGF-I message in brain was not influenced by hypophysectomy. IGF-I infusion induced a small increase in its own mRNA in skeletal muscle and WAT, whereas it decreased its own message in liver. IGFBPs were expressed in a tissue-specific manner; IGFBP-2 mRNA was most abundant in testes and hypophysectomized liver, IGFBP-3 mRNA was most abundant in spleen, kidney, WAT, and liver, IGFBP-4 mRNA was most abundant in liver, and IGFBP-5 mRNA was most abundant in kidney, WAT, and skeletal muscle. After hypophysectomy, significant decreases in IGFBP expression were observed in liver (except IGFBP-2), skeletal muscle, brain, WAT (except IGFBP-4), and testes (except IGFBP-2), in contrast to heart, kidney, spleen, and thymus. GH infusion did not affect IGFBP-2 mRNA levels in liver (in contrast to IGF-I infusion) or brain. Like GH, IGF-I normalized IGFBP-3 mRNA levels in liver, but, in contrast to GH, had no effect on IGFBP-5 mRNA in WAT. It was considerably less effective than GH in raising IGFBP-5 mRNA levels in skeletal muscle. Thus, GH infusion can exert different effects on IGF-I and IGFBP expression than infused rhIGF-I. Differences may be due to direct actions of GH at the tissue level, including auto/paracrine effects of locally produced IGF-I.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527334     DOI: 10.1210/endo.135.6.7527334

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Distinct alterations in chromatin organization of the two IGF-I promoters precede growth hormone-induced activation of IGF-I gene transcription.

Authors:  Dennis J Chia; Jennifer J Young; April R Mertens; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2010-02-16

Review 3.  Body size regulation and insulin-like growth factor signaling.

Authors:  Seogang Hyun
Journal:  Cell Mol Life Sci       Date:  2013-03-19       Impact factor: 9.261

Review 4.  Insulin-like growth factor I: an attractive option for chronic heart failure?

Authors:  M Y Donath; J Zapf
Journal:  Drugs Aging       Date:  1999-10       Impact factor: 3.923

5.  Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients.

Authors:  C Matuschek; M Rudoy; M Peiper; P A Gerber; N P Hoff; B A Buhren; B Flehmig; W Budach; W T Knoefel; H Bojar; H B Prisack; G Steinbach; V Shukla; A Schwarz; K Kammers; A Erhardt; A Scherer; E Bölke; M Schauer
Journal:  Eur J Med Res       Date:  2011-10-10       Impact factor: 2.175

6.  The anabolic effects of recombinant human growth hormone and glutamine on parenterally fed, short bowel rats.

Authors:  Yan Gu; Zhao-Han Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

7.  The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men.

Authors:  M Hameed; K H W Lange; J L Andersen; P Schjerling; M Kjaer; S D R Harridge; G Goldspink
Journal:  J Physiol       Date:  2003-10-17       Impact factor: 5.182

8.  Modulation of brain insulin-like growth factor I (IGF-I) binding sites and hypothalamic GHRH and somatostatin levels by exogenous growth hormone and IGF-I in juvenile rats.

Authors:  Rina Eshet; Irit Gil-Ad; Olga Apelboym; Yael Segev; Moshe Phillip; Haim Werner
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 9.  Regulation of muscle mass by growth hormone and IGF-I.

Authors:  C P Velloso
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

10.  Chronic alterations in growth hormone/insulin-like growth factor-I signaling lead to changes in mouse tendon structure.

Authors:  R H Nielsen; N M Clausen; P Schjerling; J O Larsen; T Martinussen; E O List; J J Kopchick; M Kjaer; K M Heinemeier
Journal:  Matrix Biol       Date:  2013-09-28       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.